Global Cardiac Point of Care POCs Market Size By Type (Blood Tests Including Cholesterol, Coagulation Testing), By Application (Hospitals, Cardiac Centers), By Region, And Segment Forecasts, 2023 to 2...

The Global Cardiac Point of Care (POC) Market was valued at USD 2.9 billion in 2023 and is projected to reach USD 5.6 billion by 2031, growing at a CAGR of 8.7% during the forecast period from 2023 to 2031. This robust market growth is driven by the rising prevalence of cardiovascular diseases, increasing demand for rapid diagnostics, and advancements in portable testing technologies. Cardiac POC testing devices provide critical, real-time diagnostic data at or near the site of patient care, reducing treatment delays and improving patient outcomes, especially in emergency and primary care settings.

Drivers:

1. Rising Prevalence of Cardiovascular Diseases (CVDs):

The global increase in heart-related conditions such as myocardial infarction, arrhythmias, and heart failure is intensifying the need for fast, reliable diagnostics. Cardiac POC devices offer timely detection of cardiac biomarkers, enabling early intervention and reducing mortality rates.

2. Demand for Rapid and Decentralized Diagnostics:

As healthcare systems shift towards patient-centric and decentralized care, the demand for rapid, portable testing solutions at the point of care is soaring. POC devices enable immediate clinical decisions, particularly in emergency departments and ambulances.

3. Technological Innovations in Biosensors and Miniaturization:

Recent advancements in microfluidics, biosensors, and wireless connectivity have enhanced the accuracy, usability, and connectivity of cardiac POC systems, allowing for real-time data transmission and integration with electronic medical records (EMRs).

Restraints:

1. High Cost of Advanced POC Devices:

Despite their clinical advantages, the upfront cost and ongoing maintenance of advanced cardiac POC instruments can hinder adoption, particularly in resource-limited settings.

2. Regulatory Challenges and Standardization Issues:

Varying regulatory landscapes and the lack of uniform standards for POC diagnostic accuracy and reliability may slow down the global expansion of these devices.

Opportunity:

1. Growth Potential in Emerging Markets:

Asia-Pacific, Latin America, and parts of Africa present untapped potential due to increasing investments in healthcare infrastructure and the growing burden of cardiac diseases.

2. Integration with AI and Digital Health Platforms:

The integration of cardiac POC devices with AI-powered analytics and telemedicine platforms can offer predictive insights and remote monitoring capabilities, creating new business models and patient engagement strategies.

Market by System Type Insights:

By system type, the Portable Analyzer Devices segment dominated the market in 2023, owing to their ease of use, portability, and ability to deliver quick test results at the bedside. This segment is expected to continue its dominance, supported by increasing demand in critical care and ambulatory settings.

On the other hand, Bench-top Analyzers remain crucial in clinical labs and emergency departments due to their higher throughput and comprehensive biomarker testing capabilities.

Market by End-use Insights:

Hospitals and Clinics were the largest end-use segment in 2023, accounting for over 50% of global revenue. These settings require rapid diagnostics to initiate immediate treatment for cardiac events.

The Ambulatory Surgical Centers and Home Care Settings segments are expected to witness the fastest growth due to the increasing trend of decentralized care and chronic disease monitoring at home, especially among elderly populations.

Market by Regional Insights:

North America led the global cardiac POC market in 2023, supported by a mature healthcare infrastructure, rising incidence of heart disease, and early adoption of advanced diagnostics.

Asia-Pacific is projected to be the fastest-growing region during the forecast period, driven by increasing healthcare spending, rising awareness, and government initiatives focused on cardiovascular health.

Competitive Scenario:

Key players in the Global Cardiac Point of Care Market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, QuidelOrtho Corporation, bioMérieux SA, Beckman Coulter (Danaher), Alere Inc., and i-STAT Corporation. These companies are focusing on continuous innovation, regional expansion, and strategic collaborations to strengthen their market presence.

Notable Developments:

2023: Abbott launched a next-gen handheld troponin test with AI-enhanced analytics for early heart attack detection.

2024: Roche announced a strategic collaboration with a telehealth provider to integrate cardiac POC testing with remote patient monitoring.

2025: Siemens Healthineers introduced a portable multi-biomarker POC device for use in ambulances and mobile clinics.

Scope of Work – Global Cardiac Point of Care (POC) Market

Report Metric Details

Market Size (2023) USD 2.9 billion

Projected Market Size (2031) USD 5.6 billion

CAGR (2023–2031) 8.7%

Key Segments By System Type (Portable, Bench-top), By End-use (Hospitals, Home Care)

Growth Drivers Increasing CVD burden, demand for rapid testing, technological innovation

Opportunities AI integration, expansion in emerging markets

FAQs:

1. What is the current market size of the Global Cardiac Point of Care (POC) Market?

The market was valued at USD 2.9 billion in 2023.

2. What is the major growth driver of the Global Cardiac Point of Care (POC) Market?

The key driver is the increasing demand for rapid diagnostics due to the global rise in cardiovascular diseases.

3. Which is the largest region during the forecast period in the Global Cardiac Point of Care (POC) Market?

North America currently dominates the market, while Asia-Pacific is expected to grow the fastest.

4. Which segment accounted for the largest market share in the Global Cardiac Point of Care (POC) Market?

The Portable Analyzer Devices segment held the largest share in 2023.

5. Who are the key market players in the Global Cardiac Point of Care (POC) Market?

Key players include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and QuidelOrtho Corporation.